Filing Flows › Outset Medical (OM) › Q2 2026 › vs Q1 2026
Outset Medical (OM) Q2 2026 vs Q1 2026 (quarter over quarter)
Outset Medical's revenue rose $3.8M (+14%) from $27.9M in Q1 2026 to $31.6M in Q2 2026. The biggest changes: Product +$3.4M (+18%); Service and Other Revenue +$414K (+4%).
Outset Medical, Q2 2026: revenue $31.6M (+0.7% year over year), operating margin -49.6%, net loss $18.0M, operating cash flow −$9.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Consumables Product | $12.4M | $13.2M | −$760K | -6% |
| Consoles Product | $9.5M | $5.4M | $4.1M | +77% |
| Product | $21.9M | $18.6M | $3.4M | +18% |
| Service and Other Revenue | $9.7M | $9.3M | $414K | +4% |
| Revenue | $31.6M | $27.9M | $3.8M | +14% |
| Net loss | $18.0M | $19.0M | −$994K | -5% |
| Costs & expenses | $49.6M | $46.8M | $2.8M | +6% |
| Operating costs | $47.3M | $44.8M | $2.5M | +6% |
| Interest & other, net | $2.1M | $1.8M | $246K | +13% |
| Income tax | $220K | $217K | $3K | +1% |
| Cost of revenue | $18.4M | $15.8M | $2.6M | +16% |
| Research & development | $5.5M | $5.6M | −$168K | -3% |
| Sales & marketing | $12.2M | $13.3M | −$1.1M | -8% |
| General & admin | $11.4M | $10.1M | $1.2M | +12% |
| Operating cash sources | $18.0M | $19.0M | −$994K | -5% |
| Depreciation & amortization | $627K | $795K | −$168K | -21% |
| Share-based compensation | $2.7M | $3.5M | −$757K | -22% |
| Working capital & other | $5.0M | $1.9M | $3.1M | +166% |
| Cash used in operations | $9.6M | $12.8M | −$3.2M | -25% |
| Net loss absorbed | $18.0M | $19.0M | −$994K | -5% |
Questions
How much did Outset Medical's revenue grow quarter over quarter in Q2 2026?
Outset Medical's revenue rose $3.8M (+14%) from $27.9M in Q1 2026 to $31.6M in Q2 2026.
What drove Outset Medical's revenue change in Q2 2026?
Product +$3.4M (+18%); Service and Other Revenue +$414K (+4%).